Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma

Cancer Investigation

Volumn 25, Issue 8, 2007, Pages 685-690

  Long, Chaozhong ^a   Yin, Bangliang ^a   Lu, Qianjin ^a   Zhou, Xinmin ^a   Hu, Jianguo ^a   Yang, Yifeng ^a   Yu, Fenglei ^a   Yuan, Yunchang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

DNA methylation; Esophageal squamous cell carcinoma; RUNX3

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

AGED; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 36849052340     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701561131     Document Type: Article

References (33)

1. Pisani, P.; Parkin, D.M.; Bray, F.; Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 1999, 83, 18-29.
2. Mori, M.; Mimori, K.; Shiraishi, T.; Alder, H.; Inoue, H.; Tanaka, Y.; Sugimachi, K.; Huebner, K.; Croce, C.M. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res. 2000, 60, 1177-1182.
3. Ishii, H.; Baffa, R.; Numata, S.I.; Murakumo, Y.; Rattan, S.; Inoue, H.; Mori, M.; Fidanza, V.; Alder, H.; Croce, C.M. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc. Natl. Acad. Sci. USA 1999, 96 (7), 3928-3933.
4. Kuroki, T.; Trapasso, F.; Shiraishi, T.; Alder, H.; Mimori, K.; Mori, M.; Croce, C.M. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer. Res. 2002, 62 (8), 2258-2260.
5. Massague, J.; Blain, S.W.; Lo, R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103 (2), 295-309.
6. Cohen, M.M.; Jr. TGF beta/Smad signaling system and its pathologic correlates. Am. J. Med. Genet. A 2003, 116 (1), 1-10.
7. Fukuchi, M.; Nakajima, M.; Miyazaki, T.; Masuda, N.; Osawa, H.; Manda, R.; Tsukada, K.; Kato, H.; Kuwano, H. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma. J. Surg. Oncol. 2006, 94 (1), 51-56.
8. Zaidi, S.K.; Sullivan, A.J.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Lian, J.B. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl. Acad. Sci. USA 2002, 99 (12), 8048-8053.
9. Du Plessis, L.; Dietzsch, E.; Van Gele, M.; VanRoy, N.; Van Helden, P.; Parker, M.I.; Mugwanya, D.K.; De Groot, M.; Marx, M.P.; Kotze, M.J.; et al. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the Black and Colored populations of South Africa. Cancer Res. 1999, 59 (8), 1877-1883.
10. Yen, C.C.; Chen, Y.J.; Chen, J.T.; Hsia, J.Y.; Chen, P.M.; Liu, J.H.; Fan, F.S.; Chiou, T.J.; Wang, W.S.; Lin, C.H. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001, 92 (11), 2769-2777.
11. Li, Q.L.; Ito, K.; Sakakura, C.; Fukamachi, H.; Inoue, K.; Chi, X.Z.; Lee, K.Y.; Nomura, S.; Lee, C.W.; Han, S.B.; et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109 (1), 113-124.
12. Kim, T.Y.; Lee, H.J.; Hwang, K.S.; Lee, M.; Kim, J.W.; Bang, Y.J.; Kang, G.H. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest. 2004, 84 (4), 479-484.
13. Wada, M.; Yazumi, S.; Takaishi, S.; Hasegawa, K.; Sawada, M.; Tanaka, H.; Ida, H.; Sakakura, C.; Ito, K.; Ito, Y.; et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004, 23 (13), 2401-2407.
14. Gabbert, H.E.; Nakamura, Y.; Shimoda, T.; Field, J.K.; Hainaut, P.; Inoue, H. Tumors of the oessophagus; IARC Press: Lyon, 2000.
15. Park, W.S.; Cho, Y.G.; Kim, C.J.; Song, J.H.; Lee, Y.S.; Kim, S.Y.; Nam, S.W.; Lee, S.H.; Yoo, N.J.; Lee, J.Y. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp. Mol. Med. 2005, 37 (4), 276-281.
16. Lu, Q.; Richardson, B. Methods for Analyzing the Role of DNA Methylation and Chromatin Structure in Regulating T Lymphocyte Gene Expression. Biol. Proced. Online 2004, 6, 189-203.
17. Herman, J.G.; Graff, J.R.; Myohanen, S.; Nelkin, B.D.; Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996, 93 (18), 9821-9826.
18. Mori, T.; Nomoto, S.; Koshikawa, K.; Fujii, T.; Sakai, M.; Nishikawa, Y.; Inoue, S.; Takeda, S.; Kaneko, T.; Nakao, A. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int. 2005 25 (2), 380-388.
19. Toyota, M.; Ahuja, N.; Ohe-Toyota, M.; Herman, J.G.; Baylin, S.B.; Issa, J.P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 1999, 96 (15), 8681-8686.
20. Tokugawa, T.; Sugihara, H.; Tani, T.; Hattori, T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res. 2002, 62 (17), 4938-4944.
21. Abbaszadegan, M.R.; Raziee, H.R.; Ghafarzadegan, K.; Shakeri, M.T.; Afsharnezhad, S.; Ghavamnasiry, M.R. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int. J. Gastrointest Cancer. 2005, 36 (1), 47-54.
22. Noguchi, T.; Takeno, S.; Kimura, Y.; Uchida, Y.; Daa, T.; Yokoyama, S.; Gabbert, H.E.; Mueller, W. FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Int. J. Mol. Med. 2003, 11 (4), 441-447.
23. Fang, M.Z.; Jin, Z.; Wang, Y.; Liao, J.; Yang, G.Y., Wang, L.D.; Yang, C.S. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int. J. Oncol. 2005, 26 (3), 615-622.
24. Takeno, S.; Noguchi, T.; Fumoto, S.; Kimura, Y.; Shibata, T.; Kawahara, K. E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am. J. Clin. Pathol. 2004, 122 (1), 78-84.
25. Bae, S.C.; Choi, J.K. Tumor suppressor activity of RUNX3. Oncogene 2004, 23 (24), 4336-4340.
26. Imamura, Y.; Hibi, K.; Koike, M.; Fujiwara, M.; Kodera, Y.; Ito, K.; Nakao, A. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer. Anticancer Res. 2005, 25 (4), 2627-2630.
27. Kloos, D.U.; Choi, C.; Wingender, E. The TGF-beta-Smad network: introducing bioinformatic tools. Trends Genet 2002, 18 (2), 96-103.
28. Moustakas, A.; Pardali, K.; Gaal, A.; Heldin, C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 2002, 82 (1-2), 85-91.
29. Blobe, G.C.; Schiemann, W.P.; Lodish, H.F. Role of transforming growth factor beta in human disease. N Engl. J. Med. 2000, 342 (18), 1350-1358.
30. Schwab, M.; Praml, C.; Amler, L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 1996, 16 (4), 211-229.
31. Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21 (35), 5400-5413.
32. Baylin, S.B.; Herman, J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends. Genet. 2000, 16 (4), 168-174.
33. Maruyama, R.; Toyooka, S.; Toyooka, K.O.; Virmani, A.K.; Zochbauer-Muller, S.; Farinas, A.J.; Minna, J.D.; McConnell, J.; Frenkel, E.P.; Gazdar, A.F. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 2002, 8 (2), 514-519.